ALBIO — Biosynex SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Biosynex SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	FAS	FAS	FAS	FAS	FAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2.51	36.8	132	87.2	26.2
Net Total Accounts Receivable
Net Total Receivables	4.66	17.3	34.7	33.6	21.3
Total Inventory
Total Other Current Assets
Total Current Assets	16.1	87.5	199	160	91.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.998	2.36	5.26	8.74	16.1
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	47	126	269	260	242
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.4	49.1	67.3	39.7	51.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	16.5	59.8	101	97.8	117
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	30.5	66.3	168	163	124
Total Liabilities & Shareholders' Equity	47	126	269	260	242
Total Common Shares Outstanding